Filing Details

Accession Number:
0001181431-10-008215
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-10 12:00:00
Reporting Period:
2010-02-08
Filing Date:
2010-02-10
Accepted Time:
2010-02-10 18:05:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138412 Genoptix Inc GXDX Services-Medical Laboratories (8071) 330840570
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1414839 D Samuel Riccitelli C/O Genoptix, Inc.
1811 Aston Avenue
Carlsbad CA 92008
Ex Vp And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-08 549 $1.24 32,726 No 4 M Direct
Common Stock Acquisiton 2010-02-08 6,756 $0.38 39,482 No 4 M Direct
Common Stock Disposition 2010-02-08 6,587 $31.13 32,895 No 4 S Direct
Common Stock Disposition 2010-02-08 718 $32.23 32,177 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2010-02-08 549 $0.00 549 $1.24
Common Stock Employee Stock Option (right to buy) Disposition 2010-02-08 6,756 $0.00 6,756 $0.38
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,289 2016-07-16 No 4 M Direct
31,833 2014-05-25 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 16, 2009.
  2. The range of sale prices received is $30.85 to $31.6501. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
  3. The range of sale prices received is $32.0501 to $32.40. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
  4. Immediately exercisable.